Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis
about
Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studiesEffects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.Serum uric acid and disorders of glucose metabolism: the role of glycosuriaHyperuricemia and cardiovascular disease risk.Effect of rosuvastatin on hyperuricemic rats and the protective effect on endothelial dysfunctionManagement of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of NephropathyEffect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus.Serum Uric Acid Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: a Systematic Review and Meta-analysis.Higher Serum Uric Acid May Contribute to Cerebral Infarction in Patients with Type 2 Diabetes Mellitus: a Meta-Analysis.The Role of Uric Acid for Predicting Future Metabolic Syndrome and Type 2 Diabetes in Older People.Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes.Hyperuricaemia in patients with type 2 diabetes in a tertiary healthcare centre in sub-Saharan Africa: prevalence and determinants.Association between the hypertriglyceridemic waist phenotype and hyperuricemia: a cross-sectional study.Consumption of sucrose-sweetened soft drinks increases plasma levels of uric acid in overweight and obese subjects: a 6-month randomised controlled trial.Physiology of Hyperuricemia and Urate-Lowering Treatments.Langfassung zur S2e-Leitlinie Gichtarthritis (fachärztlich)
P2860
Q33770852-4D923ADF-776B-4AAF-8E4E-A538B169E72FQ33845734-081A2C1D-EC13-4993-AE47-B7DE6C4B63F9Q34272447-45306CB5-F810-4C98-851F-FE10A3D75CAEQ34437057-679F1143-3BB9-4703-8683-77EAC1AF85A7Q34445093-68F7A3E3-D4F1-4BEF-8C38-5CB8C1A2E2F4Q36373688-747C9551-8BA5-4724-B29C-1EBE75C5ED0DQ37320504-4D9785B8-FE1B-4A30-8053-102ACCCCF681Q38314588-77864EDC-319E-4162-9B38-95385A3E3222Q38376990-4DC3E40D-9D6F-4FAF-A057-7DE7692B0DEFQ38752415-4EA42BCA-26EA-4129-8576-E8E322CE25B5Q39170860-AA574173-DC38-4036-B0D5-BA5951DDEC5DQ40101002-F6F6EE52-D74D-4B16-9818-66974DEB938FQ53514718-AAC7027A-DFD0-42E7-8C59-645AC8C50CEDQ53837691-6F1AF36C-9236-4134-B5C7-65ACDF95623DQ55163806-7C4FF74D-FE82-4E99-9275-59E49063C54AQ56637250-C9BF3BB6-D118-40AF-A683-722853FF6032
P2860
Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Hyperuricemia as an independen ...... etes patients: a meta-analysis
@ast
Hyperuricemia as an independen ...... etes patients: a meta-analysis
@en
type
label
Hyperuricemia as an independen ...... etes patients: a meta-analysis
@ast
Hyperuricemia as an independen ...... etes patients: a meta-analysis
@en
prefLabel
Hyperuricemia as an independen ...... etes patients: a meta-analysis
@ast
Hyperuricemia as an independen ...... etes patients: a meta-analysis
@en
P2093
P2860
P1433
P1476
Hyperuricemia as an independen ...... etes patients: a meta-analysis
@en
P2093
Chong Shen
Glenn Matfin
Xiaohong Wu
P2860
P304
P356
10.1371/JOURNAL.PONE.0078206
P407
P577
2013-10-24T00:00:00Z